×
About 34,658 results

ALLMedicine™ Inflammatory Bowel Disease Center

Research & Reviews  12,102 results

The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal ...
https://doi.org/10.1093/ibd/izab339
Inflammatory Bowel Diseases; Kaplan GG, Underwood FE et. al.

Jan 16th, 2022 - Cases of coronavirus disease 2019 (COVID-19) have emerged in discrete waves. We explored temporal trends in the reporting of COVID-19 in inflammatory bowel disease (IBD) patients. The Surveillance Epidemiology of Coronavirus Under Research Exclusi...

Performing Surveillance Endoscopy for Patients with Inflammatory Bowel Disease.
https://doi.org/10.1016/j.gie.2022.01.003
Gastrointestinal Endoscopy; Mahadevan U

Jan 16th, 2022 - Performing Surveillance Endoscopy for Patients with Inflammatory Bowel Disease.|2022|Mahadevan U,|

Risk Factors for Incident Inflammatory Bowel Disease According to Disease Phenotype.
https://doi.org/10.1016/j.cgh.2022.01.003
Clinical Gastroenterology and Hepatology : the Official C... Lopes EW, Lochhead P et. al.

Jan 16th, 2022 - We examined whether relationships between known risk factors for Crohn's disease (CD) and ulcerative colitis (UC) differ according to disease phenotype, defined by Montreal classification, at the time of diagnosis. We performed a prospective cohor...

Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin ...
https://doi.org/10.14309/ctg.0000000000000450 10.7754/Clin.Lab.2019.190918
Clinical and Translational Gastroenterology; Stallhofer J, Veith L et. al.

Jan 15th, 2022 - Iron deficiency and vitamin D deficiency are common comorbidities in inflammatory bowel disease (IBD). Accumulating evidence indicates that active 1,25-dihydroxyvitamin D (1,25(OH)D) may enhance iron absorption by suppressing hepcidin. We investig...

Factors Affecting Initial Humoral Immune Response to SARS-Cov-2 Vaccines among Patients...
https://doi.org/10.14309/ajg.0000000000001619
The American Journal of Gastroenterology; Kappelman MD, Weaver KN et. al.

Jan 15th, 2022 - Although an additional COVID-19 vaccine dose for immunocompromised persons has been recommended in some countries, further data to guide vaccination strategies for patients with Inflammatory Bowel Disease (IBD) is urgently needed. We sought to ide...

see more →

Guidelines  38 results

AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dy...
https://doi.org/10.1053/j.gastro.2021.05.063
Gastroenterology Murthy SK, Feuerstein JD et. al.

Aug 22nd, 2021 - Improvements in disease management, as well as endoscopic technology and quality, have dramatically changed the way in which we conceptualize and manage inflammatory bowel disease-related dysplasia over the past 20 years. Based on evolving literat...

Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations ...
https://doi.org/10.1053/j.gastro.2021.04.034
Gastroenterology Jones JL, Tse F et. al.

Aug 3rd, 2021 - The effectiveness and safety of vaccinations can be altered by immunosuppressive therapies, and perhaps by inflammatory bowel disease (IBD) itself. These recommendations developed by the Canadian Association of Gastroenterology and endorsed by the...

Non-invasive diagnosis and follow-up of primary sclerosing cholangitis.
https://doi.org/10.1016/j.clinre.2021.101775
Clinics and Research in Hepatology and Gastroenterology; Chazouillères O, Potier P et. al.

Aug 1st, 2021 - Primary sclerosing cholangitis (PSC) is a rare and chronic cholestatic liver disease of unknown cause commonly associated with inflammatory bowel disease (IBD) and characterized by progressive obliterative fibro-inflammation of the biliary tree. A...

WSES-AAST guidelines: management of inflammatory bowel disease in the emergency setting.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111988
World Journal of Emergency Surgery : WJES; De Simone B, Davies J et. al.

May 12th, 2021 - Despite the current therapeutic options for the treatment of inflammatory bowel disease, surgery is still frequently required in the emergency setting, although the number of cases performed seems to have decreased in recent years. The World Socie...

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammat...
https://doi.org/10.1093/ecco-jcc/jjab052
Journal of Crohn's & Colitis; Kucharzik T, Ellul P et. al.

Mar 18th, 2021 - ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease.|2021|Kucharzik T,Ellul P,Greuter T,Rahier JF,Verstockt B,|adverse effects,therapeutic use,complications,drug therapy,immunology,complications...

see more →

Drugs  31 results see all →

Clinicaltrials.gov  362 results

Safety and Efficacy of Tofacitinib for Chronic Granulomatous Disease With Inflammatory Complications
https://clinicaltrials.gov/ct2/show/NCT05104723

Jan 14th, 2022 - This is a phase 1/2 open-label trial to study the safety and to explore the biological efficacy of tofacitinib in patients with confirmed and symptomatic inflammatory complications (gastrointestinal [GI], skin, lung) related to chronic granulomato...

Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab
https://clinicaltrials.gov/ct2/show/NCT03798691

Jan 13th, 2022 - The purpose of this study is to determine the immunogenicity of the herpes zoster subunit vaccine in inflammatory bowel disease patients on vedolizumab compared to those on anti-tumor necrosis factor (TNF) monotherapy. The study will evaluate humo...

High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease
https://clinicaltrials.gov/ct2/show/NCT02629120

Jan 11th, 2022 - Chronic Granulomatous Disease (CGD) is an inherited disorder resulting from a failure to produce nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, necessary for protection against a number of infectious organisms. Patients are subject t...

A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers
https://clinicaltrials.gov/ct2/show/NCT04232228

Jan 6th, 2022 - The purpose of this study is to describe the Crohn's Disease (CD)-related secondary healthcare resource utilisation of patients in the 6 months pre- and 12 months post-activation of Care4Today® inflammatory bowel disease (C4T IBD) alongside standa...

Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inf...
https://clinicaltrials.gov/ct2/show/NCT03606499

Jan 6th, 2022 - The purpose of this study is to assess the effectiveness of ustekinumab on extra-intestinal manifestations (EIMs) and immune-mediated inflammatory diseases (IMIDs) associated with inflammatory bowel disease (IBD) (both Crohn's Disease [CD] and Ulc...

see more →

News  1,284 results

Fast Five Quiz: Management of Crohn Disease
https://www.medscape.com/viewarticle/962584

Jan 12th, 2022 - Crohn disease is an idiopathic, chronic inflammatory bowel disease characterized by cycles of relapse and remission. Asymptomatic periods can last for several months and up to several years. Initiation of early treatment is critical in preventing ...

Fast Five Quiz: Diagnosis of Crohn Disease
https://www.medscape.com/viewarticle/962583

Jan 12th, 2022 - Crohn disease is a chronic inflammatory bowel disease (IBD) characterized by a relapsing cycle of transmural inflammation involving any part of the gastrointestinal (GI) tract. Over time, such chronic inflammation can result in tissue damage. The ...

Fast Five Quiz: Signs and Symptoms of Crohn Disease
https://www.medscape.com/viewarticle/962586

Jan 12th, 2022 - Crohn disease is an idiopathic, inflammatory bowel disease (IBD) that results in aberrant immune response to enteric microbiota throughout the gastrointestinal tract. The prevalence and incidence of IBD is increasing worldwide, with the highest ra...

Real-World Practice Informs Tofacitinib Use in Ulcerative Colitis
https://www.medscape.com/viewarticle/966187

Jan 6th, 2022 - A real-world analysis of tofacitinib, presented at the annual Advances in Inflammatory Bowel Disease conference, confirms that long-term use of the selective immunosuppressant agent tofacitinib is associated with high rates of steroid-free remissi...

Few Patients With IBD Receive Early Vedolizumab
https://www.medscape.com/viewarticle/965683

Dec 28th, 2021 - Real-world practice data show that less than 10% of patients with inflammatory bowel disease (IBD) receive early treatment with monoclonal antibody vedolizumab, despite better outcomes with earlier initiation. That said, earlier initiation of vedo...

see more →

Patient Education  46 results see all →